Travere Therapeutics Wins FDA Approval for FILSPARI in FSGS
San Diego, California | April 13, 2026 Travere Therapeutics, Inc. has announced that the U.S. Food and Drug Administration...
sparsentan
Advertisement
Renalys Reports Strong Phase III Results for Sparsentan in IgAN
Tokyo, Japan, November 26 2025 — Renalys Pharma has announced positive topline results from its Phase III clinical study...
Advertisement
